UnitedHealth Group Incorporated $UNH Shares Sold by IFP Advisors Inc

IFP Advisors Inc trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,233 shares of the healthcare conglomerate’s stock after selling 5,562 shares during the period. IFP Advisors Inc’s holdings in UnitedHealth Group were worth $16,306,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Sarver Vrooman Wealth Advisors acquired a new position in shares of UnitedHealth Group during the fourth quarter worth about $25,000. Nalls Sherbakoff Group LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $27,000. Lifetime Wealth Management P.C. purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $29,000. Wilkerson Advisory Group LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Aberdeen Wealth Management LLC purchased a new position in shares of UnitedHealth Group in the second quarter valued at $31,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.19% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on UNH shares. Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $397.00 to $485.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Wall Street Zen raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. HC Wainwright set a $492.00 price target on UnitedHealth Group in a report on Wednesday, May 27th. Robert W. Baird upgraded UnitedHealth Group from an “underperform” rating to a “neutral” rating and lifted their price objective for the stock from $287.00 to $453.00 in a report on Thursday, July 16th. Finally, Royal Bank Of Canada increased their target price on UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a research note on Friday, July 17th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $456.56.

UnitedHealth Group Stock Up 1.0%

NYSE:UNH opened at $401.25 on Wednesday. The stock has a 50-day simple moving average of $410.91 and a 200 day simple moving average of $366.22. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The company has a market capitalization of $360.16 billion, a price-to-earnings ratio of 25.82, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business’s revenue was up .4% on a year-over-year basis. During the same quarter last year, the firm earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 19.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s dividend payout ratio is currently 59.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.